Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (261-270 of 340) with videos related to

Pageof 34
Sort By:
Biology|May 26, 2026
Fecal ACE and ACE2 Activities Reflect Intestinal Shedding and Microbiota Modulation of Renin-Angiotensin SystemMariana Ferreira-Duarte, Clara Quintas, Joana Bom, et al.
Autoimmunity Reviews|May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Journal of Crohn'S & Colitis|March 1, 2018
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical TrialEugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Ulcerative colitis in northern Portugal and Galicia in SpainManuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|April 6, 2019
Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical TrialEugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative ColitisMárcia S Pereira, Cecília Durães, Telmo A Catarino, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical eventsFernando Magro, Manuel Barreiro-de Acosta, Paula Lago, et al.
Journal of Crohn'S & Colitis|July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension StudyEdward V Loftus, Geert D'Haens, Edouard Louis, et al.
Pageof 34

Showing results (261-270 of 340) with videos related to

Sort By:
Pageof 34
Biology|May 26, 2026
Fecal ACE and ACE2 Activities Reflect Intestinal Shedding and Microbiota Modulation of Renin-Angiotensin SystemMariana Ferreira-Duarte, Clara Quintas, Joana Bom, et al.
Autoimmunity Reviews|May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Journal of Crohn'S & Colitis|March 1, 2018
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical TrialEugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Ulcerative colitis in northern Portugal and Galicia in SpainManuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|April 6, 2019
Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical TrialEugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative ColitisMárcia S Pereira, Cecília Durães, Telmo A Catarino, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical eventsFernando Magro, Manuel Barreiro-de Acosta, Paula Lago, et al.
Journal of Crohn'S & Colitis|July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension StudyEdward V Loftus, Geert D'Haens, Edouard Louis, et al.
Pageof 34